1.11
전일 마감가:
$1.08
열려 있는:
$1.07
하루 거래량:
274.78K
Relative Volume:
0.96
시가총액:
$99.57M
수익:
-
순이익/손실:
$-30.15M
주가수익비율:
-1.2198
EPS:
-0.91
순현금흐름:
$-31.63M
1주 성능:
-5.13%
1개월 성능:
+0.91%
6개월 성능:
+27.64%
1년 성능:
-50.22%
Context Therapeutics Inc Stock (CNTX) Company Profile
명칭
Context Therapeutics Inc
전화
267-225-7416
주소
2001 MARKET STREET, PHILADELPHIA
CNTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
CNTX
Context Therapeutics Inc
|
1.11 | 96.88M | 0 | -30.15M | -31.63M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Context Therapeutics Inc Stock (CNTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-18 | 개시 | Guggenheim | Buy |
| 2025-04-21 | 개시 | William Blair | Outperform |
| 2025-01-08 | 개시 | JMP Securities | Mkt Outperform |
| 2024-11-25 | 개시 | D. Boral Capital | Buy |
| 2024-05-16 | 개시 | Piper Sandler | Overweight |
Context Therapeutics Inc 주식(CNTX)의 최신 뉴스
Is Context Therapeutics Inc. a candidate for recovery playAnalyst Upgrade & Low Drawdown Investment Strategies - newser.com
Is Context Therapeutics Inc. stock a safe buy before earningsWeekly Trend Report & Entry Point Strategy Guides - newser.com
Is Context Therapeutics Inc. stock poised for growthMarket Sentiment Report & Short-Term High Return Strategies - newser.com
Why analysts remain bullish on Context Therapeutics Inc. stockWeekly Stock Recap & Low Drawdown Investment Ideas - newser.com
How to interpret RSI for Context Therapeutics Inc. stockOptions Play & AI Powered Market Entry Strategies - newser.com
Why hedge funds are buying Context Therapeutics Inc. stockNew Guidance & Verified Momentum Stock Watchlist - newser.com
Does Context Therapeutics Inc. stock trade at a discount to peersWeekly Investment Summary & Fast Moving Trade Plans - newser.com
Is Context Therapeutics Inc. stock a defensive play in 2025Quarterly Market Summary & Verified Chart Pattern Signals - newser.com
Is Context Therapeutics Inc. stock positioned well for digital economyInsider Buying & Reliable Breakout Forecasts - newser.com
Using portfolio simulators with Context Therapeutics Inc. includedJuly 2025 Selloffs & Verified Trade Idea Suggestions - newser.com
Is Context Therapeutics Inc. trending in predictive chart modelsWeekly Market Report & Verified Stock Trade Ideas - newser.com
Context Therapeutics Inc. stock trendline breakdownDividend Hike & Proven Capital Preservation Tips - newser.com
Real time scanner hits for Context Therapeutics Inc. explainedForecast Cut & Low Drawdown Momentum Trade Ideas - newser.com
Applying chart zones and confluence areas to Context Therapeutics Inc.July 2025 Review & Consistent Profit Trade Alerts - newser.com
Is Context Therapeutics Inc. stock a top pick in earnings seasonJuly 2025 Movers & Real-Time Volume Analysis - newser.com
What’s the recovery path for long term holders of Context Therapeutics Inc.Trade Performance Summary & Precise Swing Trade Alerts - newser.com
What recovery options are there for Context Therapeutics Inc.Portfolio Gains Report & Comprehensive Market Scan Reports - newser.com
Is Context Therapeutics Inc. stock resilient to inflationWeekly Trade Analysis & Fast Exit and Entry Strategy Plans - newser.com
Context Therapeutics Grants Stock Options to New Hire - MSN
Exit strategy if you’re trapped in Context Therapeutics Inc.July 2025 EndofMonth & Comprehensive Market Scan Insights - newser.com
What drives Context Therapeutics Inc stock priceEnergy Sector Updates & Small Budget Trading Ideas - earlytimes.in
Context Therapeutics (CNTX) Projected to Post Earnings on Wednesday - MarketBeat
Context Therapeutics Inc (CNTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Context Therapeutics Inc 주식 (CNTX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Levit Alex C. | Chief Legal Officer, Corp. Sec |
Jun 06 '25 |
Buy |
0.58 |
20,000 |
11,520 |
29,000 |
| Minai-Azary Jennifer Lynn | Chief Financial Officer |
Jun 06 '25 |
Buy |
0.64 |
40,010 |
25,486 |
80,010 |
자본화:
|
볼륨(24시간):